Asploro Journal of Biomedical and Clinical Case Reports
![Asploro Journal of Biomedical and Clinical Case Reports [ISSN: 2582-0370]](https://i0.wp.com/asploro.com/wp-content/uploads/2023/11/Asploro-Journal-of-Biomedical-and-Clinical-Case-Reports-2024.jpg?resize=853%2C1024&ssl=1)
ISSN: 2582-0370
Article Type: Case Report
DOI: 10.36502/2024/ASJBCCR.6348
Asp Biomed Clin Case Rep. 2024 May 28;7(2):126-30
Hiroshi Bando1,2,3iD*, Maki Okada3, Noboru Iwatsuki3, Tomoya Ogawa3, Kazuki Sakamoto3
1Medical Research/Tokushima University, Tokushima, Japan
2Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan
3Sakamoto Hospital, Higashi Kagawa city, Kagawa, Japan
Corresponding Author: Hiroshi Bando ORCID iD
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 04 May 2024; Accepted date: 20 May 2024; Published date: 28 May 2024
Citation: Bando H, Okada M, Iwatsuki N, Ogawa T, Sakamoto K. Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg). Asp Biomed Clin Case Rep. 2024 May 28;7(2):126-30.
Copyright © 2024 Bando H, Okada M, Iwatsuki N, Ogawa T, Sakamoto K. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Keywords: Imeglimin, Twymeeg, Pulse Wave Velocity, Ankle Brachial Index, Cardio-Ankle Vascular Index, Japan LCD Promotion Association
Abbreviations: PWV: Pulse Wave Velocityl ABI: Ankle Brachial Index; CAVI: Cardio-Ankle Vascular Index; JLCDPA: Japan LCD Promotion Association
Abstract
The patient is a 73-year-old male with type 2 diabetes (T2D) and hypertension, treated for years with various oral hypoglycemic agents (OHAs) and an anti-hypertensive agent (AHA). His HbA1c levels were unstable during 2020-2022, during which time he was prescribed linagliptin, voglibose, and metformin. In 2023, his HbA1c increased to 8.4%, and imeglimin (Twymeeg) was initiated. This resulted in an acute reduction of HbA1c to 6.5% over 5 months. A pulse wave velocity (PWV) examination, using a sphygmograph, showed stable values for the cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) over 4 years. Consequently, this patient has maintained a low level of arteriosclerosis, associated with the effective treatment using imeglimin.
